Ranbaxy is looking better pick in pharma space, says Kunal Bothra of LKP.
Bothra told CNBC-TV18, "I think at this point of time investing in defensives is a much better, much safer bet as we all know. But looking at the pharma stocks, Ranbaxy is one stock which has moved very strongly; Rs 420 was the bottom probably the last week or so.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
